510(k) K010289— SCIMEDX PHASE II MPO IGG ANTIBODY EIA

Substantially Equivalent

Scimedx Corp.

Clearance details

Applicant: Scimedx Corp.
Product code: Code MOB
Advisory panel: Immunology
Date received: 2001-01-31
Decision date: 2001-03-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Denvill, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.